Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “626”

162 pharma patents match "626" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 162
Index total 30,257
Page 2 / 7

Quick answer

This filtered view shows 162 pharmaceutical patents matching "626" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

162 results for “626” · 30,257 patents in full index Clear search

  1. US 10752626

    Iso-citrate dehydrogenase (IDH) inhibitor

    SHANGHAI METON PHARMACEUTICAL CO., LTD · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted

  2. US 10626087

    Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same

    The Board of Regents of the University of Texas System · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  3. US 10626372

    Methods and compositions for inducing hematopoietic cell differentiation

    Fate Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  4. US 10626096

    Azole derivatives as apelin receptor agonist

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  5. US 10626147

    Cell penetrating peptides and methods of making and using thereof

    Entrada Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  6. US 10626173

    Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  7. US 10626111

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  8. US 10626419

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  9. US 10626469

    Rapid identification of microorganisms

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  10. US 10626399

    Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  11. US 10626146

    α4β7 thioether peptide dimer antagonists

    Protagonist Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  12. US 10626129

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  13. US 10626094

    Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  14. US 10626145

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  15. US 10626396

    Antisense composition and method for treating muscle atrophy

    Sarepta Therapeutics, Inc. · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  16. US 10626393

    Delivering CRISPR therapeutics with lipid nanoparticles

    ARBUTUS BIOPHARMA CORPORATION · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted

  17. US 10596260

    Reoviruses having modified sequences

    ONCOLYTICS BIOTECH INC. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted

  18. US 10301626

    Catalytic strands of minimal hammerhead ribozymes and methods of using the same

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  19. US 10238626

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  20. US 10081626

    8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Sep 25, 2018 · Expires Sep 20, 2038

    granted

  21. US 9956267

    Method of treating skeletal dysplasias using vessel dilator

    United States Department of Veteran Affairs · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  22. US 9944626

    6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

    Takeda Pharmaceutical Company Limited · Granted Apr 17, 2018 · Expires Apr 12, 2038

    granted

  23. US 9862693

    Compounds and methods of treating cancer

    The Regents of the University of California · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  24. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.